Skip to content

Clinical trials

Withdrawn Hypertension, Pulmonary trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension, Pulmonary Status: Withdrawn Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20071
20082
20094
20103
20123
20132
20142
20153
20163
20174
20181
20202
20212
20223
20233
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn47

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics3
Echosense Ltd.2
Massachusetts General Hospital2
NXT Biomedical2
National Heart, Lung, and Blood Institute (NHLBI)2
University of Chicago2
Attgeno AB1
Duke University1
Elpen Pharmaceutical Co. Inc.1
Erasme University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension, Pulmonary47
Heart Failure8
Pulmonary Arterial Hypertension6
Scleroderma, Systemic3
Anemia, Sickle Cell2
Familial Primary Pulmonary Hypertension2
Heart Defects, Congenital2
Lung Diseases, Interstitial2
Persistent Fetal Circulation Syndrome2
Pulmonary Disease, Chronic Obstructive2

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.